Hemostan
Formulation
Each capsule contains:  
Tranexamic acid 250 mg or 500 mg   
Each mL of a 2.5 mL Solution for Injection contains:  
Tranexamic acid 100 mg
Each mL of a 5 mL Solution for Injection contains:  
Tranexamic acid 100 mg

Tranexamic acid

Hemostan®

Prescription Drug

Indication

For the treatment and control of excessive bleeding in various surgical and medical conditions including:

Surgical

  • General surgical cases
  • Prostatectomy

Obstetric and gynecologic

  • Menorrhagia/menometrorrhagia
  • Postpartum hemorrhage
  • Abortion
  • Conisation of the cervix

Medical

  • Epistaxis
  • Hemoptysis
  • Peptic ulcer disease with hemorrhage
  • Hematuria
  • Blood dyscrasias with hemorrhage (e.g. hemophilia)
  • Hereditary angione urotic edema

Dental

  • Following tooth extraction and dental surgery

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

 

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.